Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia
Clinical trial NCT01465230 · TERMINATED
Trial details
- NCT number
- NCT01465230
- Sponsor
- Yale University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-11-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.